NantHealth (NASDAQ:NH – Get Rating) and AcuityAds (NYSE:ATY – Get Rating) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, analyst recommendations, dividends, institutional ownership, valuation, earnings and profitability.
Insider and Institutional Ownership
4.5% of NantHealth shares are held by institutional investors. Comparatively, 8.7% of AcuityAds shares are held by institutional investors. 61.3% of NantHealth shares are held by insiders. Comparatively, 12.0% of AcuityAds shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Get NantHealth alerts:Volatility & Risk
NantHealth has a beta of 1.82, meaning that its stock price is 82% more volatile than the S&P 500. Comparatively, AcuityAds has a beta of 1.26, meaning that its stock price is 26% more volatile than the S&P 500.
Analyst Ratings
This is a summary of current ratings and price targets for NantHealth and AcuityAds, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| NantHealth | 0 | 0 | 0 | 0 | N/A |
| AcuityAds | 0 | 0 | 5 | 0 | 3.00 |
AcuityAds has a consensus target price of $3.43, suggesting a potential upside of 114.29%. Given AcuityAds' higher probable upside, analysts plainly believe AcuityAds is more favorable than NantHealth.
Earnings & Valuation
This table compares NantHealth and AcuityAds' top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| NantHealth | $67.00 million | 0.16 | -$67.78 million | ($7.65) | -0.18 |
| AcuityAds | $121.04 million | 0.75 | -$580,000.00 | ($0.01) | -160.00 |
AcuityAds has higher revenue and earnings than NantHealth. AcuityAds is trading at a lower price-to-earnings ratio than NantHealth, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares NantHealth and AcuityAds' net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| NantHealth | -101.16% | N/A | -39.91% |
| AcuityAds | -1.39% | -5.84% | -4.46% |
Summary
AcuityAds beats NantHealth on 9 of the 13 factors compared between the two stocks.
About NantHealth
(Get Rating)
NantHealth, Inc. is an evidence-based, personalized healthcare company, which engages in the provision of treatment for critical diseases such as cancer. The firm empowers treatment decisions, improves patient outcomes, validates treatment options, enables high-quality care, lowers costs, ensures appropriate reimbursement, and streamlines implementation and deployment. The company was founded by Patrick Soon-Shiong in July 2010 and is headquartered in Morrisville, NC.
About AcuityAds
(Get Rating)
AcuityAds Holdings, Inc. engages in the provision of digital advertising solutions. It operates through the following geographical segments: Unites States, Canada, and Europe and Other. The company was founded by Tal Hayek, Nathan Mekuz, Rachel Kapcan, and Joe Ontman on October 9, 2009 and is headquartered in Toronto, Canada.
Receive News & Ratings for NantHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NantHealth and related companies with MarketBeat.com's FREE daily email newsletter.